GRF-6019

N/A

Report date: 2024/12/17 20:00:06

Base Information

Drug NameGRF-6019
Drug Alias NameGRF6019GRF-6019
ClassificationBiologics > Blood components
Mechanisms of ActionNeurogenesis stimulants
TargetsNot applicable
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlkahest IncGrifols Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlkahest Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A